An interventional study of STEPPS plus Family Connections and STEPPS in Borderline Personality Disorder (BPD), sponsored by Universitat Jaume I. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-15.
Sponsored by Universitat Jaume I · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Borderline Personality Disorder with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Borderline Personality Disorder · Spain.
Among the 19 studies in Borderline Personality Disorder with a site in Spain, this one is the 7th largest by planned enrollment of the 18 interventional ones that give a count, is the only one that started in 2024, is one of 12 with no phase, and was the 18th registered.
279 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.
Browse Borderline Personality Disorder studies →4 of the 19 studies in Borderline Personality Disorder with a site in Spain are open now. Recruiting first, the newest first:
Consorci Sanitari del Maresme · Sites in Spain
Ages 18–60
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Sites in Spain
Ages 18–65
Universidad Europea de Valencia · Sites in Spain
Ages 16+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 49 Borderline Personality Disorder studies recruiting now, 18 (37%) set no upper age limit and 30 (61%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 70 across 222 interventional studies indexed under Borderline Personality Disorder.
Median enrollment 107 across the 18 interventional studies, 156 across the 1 observational. Of the 9 that completed or were terminated, 3 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 19 have an industry lead sponsor. The 10 most frequent:
Universitat Jaume I is the lead sponsor of 80 studies on the registry; 19 are open to participants now.
Universitat Jaume I has 3 studies filed under Borderline Personality Disorder — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 19 studies in Borderline Personality Disorder with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The present research project is framed within the issue of Borderline Personality Disorder (BPD). This condition stands as one of the most common challenges encountered within the mental health services of the National Health System. The primary objectives of this research are to verify whether the combined use of established treatments for patients and their families, conducted in parallel, leads to a greater improvement in patients and their families, respectively. Additionally, another aim of the project is to assess efficiency, defined as the acceptance of intervention programs by patients, their families, and clinical professionals, as well as to demonstrate their feasibility.
The literature so far seems to indicate that involving family members in psychotherapeutic interventions for patients diagnosed with Severe Mental Disorders (SMD) such as psychosis or bipolar disorder is effective, reducing hospitalizations and increasing treatment satisfaction. However, interventions with such characteristics have not been found for patients with Borderline Personality Disorder (BPD), one of the disorders included under the umbrella of SMD. Therefore, it seems necessary to develop and implement comprehensive programs involving families, given the benefits observed in other SMD diagnoses such as psychosis or bipolar disorder.
BPD is one of the personality disorders that receives significant clinical attention and research, with suicide being one of the most associated problems with this diagnosis, ranging from 3-10%. The prevalence of BPD in the general population is considered to be around 1%, rising to 12% in clinical populations and 22% in hospitalized patients. Meta-analysis studies place Linehan\'s Dialectical Behavior Therapy (DBT) and Bateman and Fonagy\'s Mentalization-Based Therapy as the two interventions with the highest level of recommendation. Another widely supported intervention is Blum\'s Systems Training for Emotional Predictability and Problem Solving (STEPPS) program, especially effective when delivered in a group format within clinical and hospital settings due to its high adaptability. However, the issues described concerning patients with BPD inevitably lead to severe consequences in their work, emotional, and social environments. Relatives of individuals with BPD are more likely to experience psychological problems, burden, and depression. Generally, when family members participate in treatments, the patient\'s relapses decrease, recovery becomes easier, and overall family well-being improves. Presently, interventions for relatives of patients with BPD exist. Family Connections (FC) has received the most empirical support. Nevertheless, to date, there have been no studies analyzing whether adding intervention programs for family members contributes to an improvement in the STEPPS program, which is precisely the aim of this current research. Specifically, the objective of this work is to compare the effectiveness of the STEPPS protocol for patients with BPD and their relatives, compared to the STEPPS protocol for patients alone and the Family Connections program for their relatives.
The Randomized Clinical Trial (RCT) will be conducted following the guidelines of the Consolidated Standards of Reporting Trials (CONSORT: http://www.consort-statement.org) and the SPIRIT guidelines (Standard Protocol Items: Recommendations for Intervention Trials). Participants (N=120) will be randomly assigned to two groups (after receiving a diagnosis of Borderline Personality Disorder according to the DSM-5): 1) STEPPS program for patients 2) STEPPS program for patients and Family Connections for their relatives. Participants in the second group may receive the Family Connections intervention for their relatives after completing the research evaluation period for ethical reasons. Outcome measures will be assessed at baseline, post-treatment, and at 6-month follow-ups. About stadistical analysis, separate statistical analyses will be performed for caregivers and patients. Intent to treat analyses will be performed using Linear Mixed Models (LMMs). The clinical significance of change observed in the scores of outcome measures from one assessment moment (baseline) to another (post-treatment) will be determined calculating the Reliable Change Indexes.
PATIENTS
Inclusion Criteria:
Exclusion Criteria:
FAMILIES:
Inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention group that receives STEPPS program for patients to carry out the intervention about BPD symptoms and in parallel another group that receives Family Connectios program for their families to carry out the intervention about associated symptoms.
Behavioral: STEPPS plus Family Connections
Intervention group that receives STEPPS program for patients only to carry out the intervention about BPD symptoms.
Behavioral: STEPPS
The intervention will be based on cognitive and behavior treatment using STEPPS for the patients and dialectical and behavior treatment using Family Connections for the families. Main components STEPPS: psychoeducation, emotional regulation skills and behavioral regulation skills. Main components Family Connections: psychoeducation, skills training and peer support.
The intervention will be based on cognitive and behavior treatment using STEPPS for the patients. Main components STEPPS: psychoeducation, emotional regulation skills and behavioral regulation skills. Waiting list group: Participant's relatives of this group will be able to receive the Family Connections intervention after the research end.
BDI: Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996).
This questionnaire assesses the degree of depressive symptomatology in the last week. It consists of 21 items rated on a scale from 0 (nothing) to 3 (very much).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months
OASIS: Overall Anxiety Severity and Impairment Scale (OASIS; Norman, Cissell, Means-Christensen, & Stein, 2006). Adapted into Spanish by Osma et al. (2019).
This questionnaire assesses the degree of anxiety symptomatology in the last week. It consists of 5 items rated on a scale from 0 (mild) to 4 (extreme).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months
INQ: The Interpersonal Needs Questionnaire (INQ; Van Order et al., 2012). We will use the Spanish version by Marco & Pérez (2016).
This questionnaire assesses the degree of interpersonal needs currently. It consists of 15 items rated on a scale from 1 (nothing true) to 7 (totally true).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
ACWRSS: The Acquired Capability with Rehearsal for Suicide Scale (ACWRSS; George et al., 2016). We will use the Spanish version by Marco et al. (2020).
This questionnaire assesses the acquired capability with rehearsal for suicide. It consists of 7 items rated on a scale from 0 (disagreement) to 8 (agreement).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
DERS: Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2008). We will use the Spanish version by Hervás & Jódar (2008).
This questionnaire assesses the ability to regulate emotions. It consists of 28 items rated on a scale from 1 (hardly never) to 5 (almost always).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
BSL-23: Borderline Symptom List 23 (BSL-23; Bohus et al., 2008). We will use the Spanish version by Feliú-Soler et al. (2012).
This questionnaire assesses the degree of symptoms of borderline personality disorders in the last week. It consists of 23 items rated on a scale from 0 (never) to 4 (very much) and 11 items rated on a scale from 0 (nothing) to 4 (daily).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
QLI: Quality of Life Index (QLI; Ferrans & Powers, 1985). We will use the Spanish version by Mezzich et al. (2000).
This questionnaire assesses the level of quality of life currently. It consists of 10 items rated on a scale from 1 (bad) to 10 (excellent).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
PIL-20: Purpose in Life-20 (PIL-20; Crumbaugh & Maholick, 1964).
This questionnaire assesses the purpose in life. It consists of 20 items rated on a scale from 1 (nothing) to 7 (very much).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
VIRS: Validating and Invalidating Responses Scale (VIRS; Fruzzetti, 2007).
This questionnaire assesses the degree of validated or invalidating responses from the family in the last week. It consists of 15 items rated on a scale from 0 (never) to 4 (almost every time).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
LEAP: Lum Emotional Availability of Parents (LEAP; Lum & Phares, 2005).
This questionnaire assesses the perception of emotional availability from the parents. It consists of 15 items rated on a scale from 0 to 6 about the father and 0 to 6 about the mother.
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
Registry of family-patient critical incidents in the last three months.
The registry consist of 6 questions about number of critical incidents such as suicide attempts or visits to the emergency room.
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
BAS: Burden Assessment Scale (BAS; Reinhard et al., 1994). Relatives's responses
This questionnaire assesses the level of disease burden in the last 6 months. It consists of 19 items rated on a scale from 1 (nothing) to 4 (very much).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
FES: Family Empowerment Scale (FES; Koren, DeChillo, & Friesen, 1992). Relatives's responses
This questionnaire assesses the degree of perception of mastery and empowerment. It consists of 34 items rated on a scale from 1 (totally false) to 4 (totally true).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
DASS-21: Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & Lovibond, 1995). We will use the Spanish version by Bados, Solanas, & Andrés (2005). Relatives's responses
This questionnaire assesses the degree of depression, anxiety and stress in the last week. It consists of 21 items rated on a scale from 0 (never) to 3 (very much).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
QLI: Quality of Life Index (QLI; Ferrans & Powers, 1985). We will use the Spanish version by Mezzich et al. (2000). Relatives's responses
This questionnaire assesses the level of quality of life currently. It consists of 10 items rated on a scale from 1 (bad) to 10 (excellent).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
SVSI-Q: The Self-Validation and Self-Invalidation Questionnaire (SVSI-Q; Fruzzetti & Davis, in preparation). Relatives's responses
This questionnaire assesses the degree of self-validation or self-invalidation. It consists of 24 items rated on a scale from 1 (hardly ever) to 5 (always).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
PIL-20: Purpose in Life-20 (PIL-20; Crumbaugh & Maholick, 1964). Relatives's responses
This questionnaire assesses the purpose in life. It consists of 20 items rated on a scale from 1 (nothing) to 7 (very much).
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
Measurement of acceptance and satisfaction. Treatment Opinion Scale (adapted from Borkovec & Nave, 1972). Relatives's responses
This questionnaire assesses the opinión about treatment at the end of the investigation. It consists of 7 items rated on a scale from 1 (nothing) to 7 (very much).
Time frame: immediately after treatment, also at follow-up assessment periods (6 months)
Registry of family-patient critical incidents in the last three months. Relatives's responses
The registry consist of 6 questions about number of critical incidents such as suicide attempts or visits to the emergency room.
Time frame: At the beginning of the intervention and immediately after treatment, also at follow-up assessment periods (6 months)
Plan to share: No
Started Jan 2024 (actual). Primary completion is estimated for Jul 2025, 17 months after the start.
Of 106 non-industry interventional studies with no phase under Borderline Personality Disorder, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 54. This study's planned 17 months is below that.
Counting every sponsor, half of 108 studies reached it within 35 months; a quarter within 24 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Borderline Personality Disorder →
Universitat Jaume I